Advertisement

Topics

Global Regenerative Medicine Market Segmented by Type of Products, Therapy and Applications Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

10:06 EDT 10 Jul 2018 | BioPortfolio Reports

The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements.


Increasing adoption of stem cell technology


Increasing adoption of stem cell technology, increasing prevalence of chronic diseases, emerging applications of gene therapy in regenerative medicine are some of the driving factors for Global Regenerative Medicine market. Technological advances in regenerative medicine stem cell, tissue engineering, and nanotechnology and high investment funding to support development of regenerative medicine are also fuelling the market growth.


Regulatory and ethical issues


Regulatory and ethical issues pertaining stem cell, tissues engineering and regenerative medicine are acting as a restraint for Regenerative Medicine market. High cost of treatments and less awareness about the regenerative medicine among people is further restraining the market.


North America to Dominate the Market


The Regenerative Medicine market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, AsiaPacific, the Middle East and Africa and South America.

North America dominates the Regenerative Medicine market due to the increasing technological advancements and high investment funding to support development of regenerative medicine. AsiaPacific is also expected to propel the Regenerative Medicine market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing economic growth.


Key developments in the market


In January, 2018: Medeor Therapeutics Awarded $18.8 Million From the California Institute for Regenerative Medicine

In January, 2018: RepliCel Life Sciences Inc. formed a partnership with the private firm, Chinabased Yofoto Health Industry Co. Ltd for regenerative medicine


Major key players: ACELITY, OSIRIS THERAPEUTICS, INC., INTEGRA LIFESCIENCES CORPORATION, ASTRAZENECA, COOK BIOTECH INCORPORATED, ORGANOGENESIS INC. and MERCK CO., INC. etc.


Reasons to purchase this report


Market analysis for the Global Regenerative Medicine Market, with regionspecific assessments and competition analysis on a global and regional scale.

Analyzing various perspectives of the company with the help of Porter's five forces analysis

The treatment type that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players.

3 months analyst support along with the Market Estimate sheet in excel.


Customization of the report


This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Original Article: Global Regenerative Medicine Market Segmented by Type of Products, Therapy and Applications Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

NEXT ARTICLE

More From BioPortfolio on "Global Regenerative Medicine Market Segmented by Type of Products, Therapy and Applications Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...